Business Context and Reporting Period
Company: Immuron Limited (Immuron)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: October 2024 (Specific date: October 16, 2024)
Context: This filing serves to disseminate a public announcement made to the Australian Securities Exchange (ASX) regarding corporate events. The registrant is a foreign private issuer based in Carlton South, Victoria, Australia.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K is an informational report regarding a corporate announcement and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing focuses solely on the scheduling of a corporate event.
Guidance, Outlook, and Management Commentary
- Corporate Event: The Chief Executive Officer (CEO) of Immuron is scheduled to participate in the Maxim Healthcare Conference.
- Announcement Details: The filing references an addendum to a previous announcement titled "IMC CEO to participate in Maxim Healthcare Conference - addendum."
- Risks and Contingencies: The filing text does not provide specific details on risks, contingencies, or unusual items beyond the standard legal disclaimer that the report is not deemed "filed" for purposes of the Exchange Act.
Key Facts for Investor Verification
- Verify the specific date and time of the CEO's participation in the Maxim Healthcare Conference by reviewing the attached Exhibit 99.1.
- Confirm if the "addendum" referenced in the announcement title contains material updates to previously disclosed conference details.
- Note that this filing does not contain financial results; investors should refer to the most recent Form 20-F or ASX announcements for financial data.